CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
14,662
edits
Cardinal Health: Difference between revisions
m
Text replacement - "Reuters" to "Reuters"
m (Text replacement - "The Wall Street Journal" to "The Wall Street Journal") |
m (Text replacement - "Reuters" to "Reuters") |
||
| Line 37: | Line 37: | ||
In 2009, Cardinal Health completed the spin-off of its clinical and medical products businesses into an independent medical technology company called [[CareFusion]] with David Schlotterbeck as CEO.<ref name="spinoff">{{cite web |url=http://www.healthcareitnews.com/news/cardinal-health-name-spinoff-after-carefusion-line-announces-amended-consent-decree |title=Cardinal Health to name spinoff after CareFusion line |newspaper=Healthcare IT News |date=February 18, 2009 |access-date=June 13, 2018}}</ref><ref>{{cite web| url=http://www.modernhealthcare.com/article/20090902/NEWS/309029953/hits-brief3-cardinal-health-completes-carefusion-spinoff%26template=emailart| title=Cardinal Health completes CareFusion spinoff| last=Rhea| first=Shawn| date=September 2, 2009| publisher=Modern Healthcare| access-date=June 10, 2015}}</ref> Cardinal Health is now traded on the [[NYSE]] under symbol CAH.<ref>{{cite web|url=https://www.google.com/finance/quote/CAH:NYSE| title=Cardinal Health Inc(NYSE:CAH)}}</ref> | In 2009, Cardinal Health completed the spin-off of its clinical and medical products businesses into an independent medical technology company called [[CareFusion]] with David Schlotterbeck as CEO.<ref name="spinoff">{{cite web |url=http://www.healthcareitnews.com/news/cardinal-health-name-spinoff-after-carefusion-line-announces-amended-consent-decree |title=Cardinal Health to name spinoff after CareFusion line |newspaper=Healthcare IT News |date=February 18, 2009 |access-date=June 13, 2018}}</ref><ref>{{cite web| url=http://www.modernhealthcare.com/article/20090902/NEWS/309029953/hits-brief3-cardinal-health-completes-carefusion-spinoff%26template=emailart| title=Cardinal Health completes CareFusion spinoff| last=Rhea| first=Shawn| date=September 2, 2009| publisher=Modern Healthcare| access-date=June 10, 2015}}</ref> Cardinal Health is now traded on the [[NYSE]] under symbol CAH.<ref>{{cite web|url=https://www.google.com/finance/quote/CAH:NYSE| title=Cardinal Health Inc(NYSE:CAH)}}</ref> | ||
In December 2013, it was announced that Cardinal Health would partner with [[CVS Caremark]] to form a generic drug sourcing operation in the United States.<ref name="cvs">{{cite news | url=https://www.reuters.com/article/us-cvs-cardinalhealth-idUSBRE9B90VB20131210 | title=CVS, Cardinal Health form U.S. generic drug venture | work= | In December 2013, it was announced that Cardinal Health would partner with [[CVS Caremark]] to form a generic drug sourcing operation in the United States.<ref name="cvs">{{cite news | url=https://www.reuters.com/article/us-cvs-cardinalhealth-idUSBRE9B90VB20131210 | title=CVS, Cardinal Health form U.S. generic drug venture | work=Reuters | date=10 December 2013 | access-date=11 December 2013 | author=Berkrot, Bill | archive-date=10 December 2013 | archive-url=https://web.archive.org/web/20131210225010/http://www.reuters.com/article/2013/12/10/us-cvs-cardinalhealth-idUSBRE9B90VB20131210 | url-status=live }}</ref> The venture was named Red Oak Sourcing and began operations in July 2014.<ref name="redoak">{{cite journal |url=https://www.bizjournals.com/columbus/blog/2014/05/cardinal-health-cvs-generics-venture-red-oak-on.html |title=Cardinal Health, CVS generics venture Red Oak on track for July start |journal=[[Columbus Business First]] |last=Ghose |first=Carrie |date=May 1, 2014 |access-date=June 13, 2018}}</ref> | ||
Between 2014 and 2016, Cardinal, alongside [[McKesson Corporation]], and [[AmerisourceBergen]], spent $13 million lobbying Congress to pass Congressman [[Tom Marino]]'s "Ensuring Patient Access and Effective Drug Enforcement Act".<ref name="WashPo16" /> The bill, which increases the burden of proof enforcers need to show against drug distributors, was signed into law by President [[Barack Obama]] in April 2016.<ref>{{USBill|114|S.|483}}, 114th Cong. (2015).</ref> | Between 2014 and 2016, Cardinal, alongside [[McKesson Corporation]], and [[AmerisourceBergen]], spent $13 million lobbying Congress to pass Congressman [[Tom Marino]]'s "Ensuring Patient Access and Effective Drug Enforcement Act".<ref name="WashPo16" /> The bill, which increases the burden of proof enforcers need to show against drug distributors, was signed into law by President [[Barack Obama]] in April 2016.<ref>{{USBill|114|S.|483}}, 114th Cong. (2015).</ref> | ||